Finance

Lists
LIMN:NASDAQ
Liminatus Pharma Inc
$3.84
+6.67%
(+0.24) 1D
$3.88
+1.04% (+0.040)
Pre-market
Closed: Sep 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LIMN...
Open
$3.86
High
$4.00
Low
$3.70
Mkt. cap
5.15M
Avg. vol.
454.54K
Volume
109.00
52-wk high
$154.50
52-wk low
$3.48
EPS
-$30.59
Beta
0.74
Shares outstanding
1.34M
No. of employees
1
Open
$3.86
High
$4.00
Low
$3.70
Mkt. cap
5.15M
Avg. vol.
454.54K
Volume
109.00
52-wk high
$154.50
52-wk low
$3.48
EPS
-$30.59
Beta
0.74
Shares outstanding
1.34M
No. of employees
1
About Liminatus Pharma Inc
CEO-
Employees1
Founded-
HeadquartersLa Palma, California, United States
SectorBiotechnology
Websiteliminatuspharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
400.00K
600.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
701.17K
884.21K
700.90K
778.91K
Operating expense
701.17K
884.21K
1.10M
1.38M
Total operating expenses
701.17K
884.21K
1.10M
1.38M
Operating income
-701.17K
-884.21K
-1.10M
-1.38M
Other non operating income
-1.66M
-101.66K
-4.18K
-29.24K
EBT including unusual items
-1.82M
-8.17M
-1.12M
-1.41M
EBT excluding unusual items
-2.38M
-1.00M
-1.12M
-1.42M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.82M
-8.17M
-1.12M
-1.41M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
8.22K
Interest expense
-19.05K
-19.05K
-18.64K
-18.84K
Net interest expenses
-19.05K
-19.05K
-18.64K
-10.62K
Depreciation and amortization charges
-
-
-
-
EBITDA
-700.63K
-883.67K
-1.10M
-1.38M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps